par Delforge, Michel;Farber, Claire 
;Späth, Peter;Kaveri, Srini Venkatesh S.;Witte, Torsten;Misbah, Siraj S.A.;Hübner, Rayk;Haerynck, Filomeen;Latinne, Dominique;Muylle, Ludo;Toungouz Nevessignsky, Michel ;Deneys, Véronique
Référence Acta clinica Belgica (Ed. multilingue), 66, 5, page (346-360)
Publication Publié, 2011
;Späth, Peter;Kaveri, Srini Venkatesh S.;Witte, Torsten;Misbah, Siraj S.A.;Hübner, Rayk;Haerynck, Filomeen;Latinne, Dominique;Muylle, Ludo;Toungouz Nevessignsky, Michel ;Deneys, VéroniqueRéférence Acta clinica Belgica (Ed. multilingue), 66, 5, page (346-360)
Publication Publié, 2011
Article révisé par les pairs
| Résumé : | The following recommendations, which aim at standardising and rationalising the clinical indications for administering polyclonal immunoglobulins in Belgium, were drawn up by a working group of the Superior Health Council. To this end, the Superior Health Council organised an expert meeting devoted to "Guidelines for the use of immunoglobulins". The experts discussed the indications for immunoglobulin use, the 'ideal' immunoglobulin preparation, its mechanisms of action, the practical issues involved in administering immunoglobulins and their potential side effects. The recommendations formulated by the experts were validated by the Superior Health Council working group with the purpose of harmonising immunoglobulin use in Belgium. |
